{"id":"https://openalex.org/W2496595447","doi":null,"title":"Role of Angiotensin Antagonists in Memory Enhancement","display_name":"Role of Angiotensin Antagonists in Memory Enhancement","alternate_titles":[],"publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2496595447","mag":"2496595447"},"language":"en","primary_location":{"id":"mag:2496595447","doi":null,"is_oa":false,"landing_page_url":"https://www.ijpbs.net/issue-3/110.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764788474","display_name":"International Journal of Pharma and Bio Sciences","issn_l":"0975-6299","issn":["0975-6299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697007","host_organization_name":"Ubitech Solutions","host_organization_lineage":["https://openalex.org/P4322697007"],"host_organization_lineage_names":["Ubitech Solutions"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharma and Bio Sciences","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2496595447"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110117116","display_name":"S. Indumathy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Indumathy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003410581","display_name":"S Kavimani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S Kavimani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"K. Venkata Raman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K. Venkata Raman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3045,"has_fulltext":false,"cited_by_count":16,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.47896032,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5615000128746033,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.5615000128746033,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.3068999946117401,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.08820000290870667,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9470000267028809},{"id":"https://openalex.org/keywords/memory-enhancement","display_name":"memory enhancement","score":0.8510000109672546},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9950000047683716},{"id":"https://openalex.org/keywords/renin-angiotensin-aldosterone-system","display_name":"renin-angiotensin-aldosterone system","score":0.9290000200271606},{"id":"https://openalex.org/keywords/angiotensin-iv","display_name":"angiotensin IV","score":0.8569999933242798},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.8299999833106995},{"id":"https://openalex.org/keywords/irbesartan","display_name":"irbesartan","score":1.0},{"id":"https://openalex.org/keywords/valsartan","display_name":"valsartan","score":1.0},{"id":"https://openalex.org/keywords/angiotensin-ii-type-1-receptor","display_name":"angiotensin II type 1 receptor","score":0.8289999961853027},{"id":"https://openalex.org/keywords/spatial-learning","display_name":"spatial learning","score":0.6650000214576721}],"concepts":[{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.7009315490722656},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.6817559003829956},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.644670844078064},{"id":"https://openalex.org/C2777387769","wikidata":"https://www.wikidata.org/wiki/Q155472","display_name":"Valsartan","level":3,"score":0.6204990148544312},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5985269546508789},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5840638279914856},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.5528563261032104},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.5112447738647461},{"id":"https://openalex.org/C2780259554","wikidata":"https://www.wikidata.org/wiki/Q947266","display_name":"Irbesartan","level":3,"score":0.44911396503448486},{"id":"https://openalex.org/C104849204","wikidata":"https://www.wikidata.org/wiki/Q24778533","display_name":"Angiotensin receptor","level":4,"score":0.437194287776947},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3953137993812561},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3749500513076782},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36431342363357544},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3638051450252533},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3455461859703064},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.28451716899871826},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"mag:2496595447","doi":null,"is_oa":false,"landing_page_url":"https://www.ijpbs.net/issue-3/110.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S2764788474","display_name":"International Journal of Pharma and Bio Sciences","issn_l":"0975-6299","issn":["0975-6299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4322697007","host_organization_name":"Ubitech Solutions","host_organization_lineage":["https://openalex.org/P4322697007"],"host_organization_lineage_names":["Ubitech Solutions"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"International Journal of Pharma and Bio Sciences","raw_type":null},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.178.2600","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.178.2600","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ijpbs.net/issue-3/110.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W164918895","https://openalex.org/W1994067502","https://openalex.org/W2001637150","https://openalex.org/W2045263244","https://openalex.org/W2058413990","https://openalex.org/W2107950227","https://openalex.org/W2134899427"],"related_works":["https://openalex.org/W7062506134","https://openalex.org/W2010122074","https://openalex.org/W2093722467","https://openalex.org/W2159280118","https://openalex.org/W2053706848","https://openalex.org/W3045199331","https://openalex.org/W2982249466","https://openalex.org/W1977116394","https://openalex.org/W1538023525"],"abstract_inverted_index":{"Alzheimer\u2019s":[0],"disease":[1],"(AD)":[2],"is":[3,66,150],"a":[4,10,47,67],"progressive":[5],"neurodegenerative":[6],"disorder":[7],"characterized":[8],"by":[9],"gradual":[11],"decline":[12],"in":[13,27,50,148],"memory":[14,118,124,155],"associated":[15],"with":[16,21],"shrinkage":[17],"of":[18,24,37,52,69,84,99,127,158],"brain":[19],"tissue,":[20],"localized":[22],"loss":[23],"neurons":[25],"mainly":[26,80],"the":[28,70,107,143,159],"hippocampus":[29],"and":[30,33,43,105,111,132,142,169],"basal":[31],"forebrain":[32],"also":[34],"diminished":[35],"level":[36],"central":[38],"cholinergic":[39],"neurotransmitter-Acetylcholine.":[40],"Renin":[41],"Angiotensin":[42,62,73,77,128],"Aldosterone":[44],"system":[45],"plays":[46],"major":[48],"role":[49],"progression":[51],"many":[53],"diseases":[54],"such":[55],"as":[56],"hypertension,":[57],"atherosclerosis,":[58],"kidney":[59],"failure":[60],"etc.,":[61],"IV":[63,110],"(Ang":[64,75],"IV)":[65],"derivative":[68],"potent":[71],"vasoconstrictor":[72],"II":[74,86,101],"II).":[76],"receptor":[78,83,104],"blockers":[79],"blocks":[81],"AT1":[82,93,103],"Ang":[85,100,109],"because":[87],"it":[88,112],"has":[89,113],"more":[90],"affinity":[91],"towards":[92],"receptor.":[94],"Hence":[95],"this":[96,122],"prevents":[97],"action":[98],"on":[102],"enhances":[106],"formation":[108],"been":[114],"proved":[115],"for":[116],"its":[117],"enhancing":[119,125,156],"property.":[120],"In":[121],"work":[123],"activity":[126],"Antagonists":[129],"Losartan,":[130],"Irbesartan":[131],"Valsartan":[133],"was":[134],"evaluated":[135],"using":[136],"Hebb\u2019s":[137],"William":[138],"maze":[139],"(Rectangular":[140],"maze)":[141],"results":[144],"shows":[145],"significant":[146,163],"increase":[147],"memory,which":[149],"comparable":[151],"between":[152],"groups":[153],"p<0.01.The":[154],"capacity":[157],"drugs":[160],"were":[161],"very":[162],"when":[164],"compared":[165],"to":[166],"normal":[167],"control":[168,171],"negative":[170],"(p<0.001).":[172]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2496595447","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-08-23T00:00:00"}
